<DOC>
	<DOCNO>NCT01149733</DOCNO>
	<brief_summary>The objective study evaluate comparative bioavailability tamsulosin hydrochloride 0.4 mg capsule ( Manufactured Teva Pharmaceutical Industries Ltd. ; distribute Teva Pharmaceuticals USA ) FlomaxÂ® ( tamsulosin hydrochloride ) 0.4 mg capsule ( Manufactured Yamanouchi Pharmaceutical Co. , Japan ; distribute Boehringer Ingelheim Pharmaceutical Inc. USA ) , single-dose healthy subject feed condition .</brief_summary>
	<brief_title>Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Healthy , nonsmoking male subject , 18 year age old . BMI great equal 19 less equal 30 . Negative : HIV . Hepatitis B surface antigen Hepatitis C antibody . Using drug abuse test ( marijuana , amphetamine , barbiturate , cocaine , opiates , benzodiazepine methadone ) . Urine cotinine test No significant disease clinically significant finding physical examination . No clinically significant abnormal laboratory value . No clinically significant finding vital sign measurement 12lead electrocardiogram ( ECG ) . Systolic blood pressure 100140 mmHg diastolic blood pressure 6090 mmgHg . Be informed nature study give write consent prior receive study procedure . Known history presence clinically significant medical condition , illness surgery within 4 week prior drug administration . Known suspect carcinoma . Known history presence : Hypersensitivity idiosyncratic reaction tamsulosin and/or drug substance similar activity . Alcoholism within last 12 month . Drug dependence and/or substance abuse . Use tobacco nicotinecontaining product within last 6 month . Use prescription medication within 14 day prior Period 1 dosing . Use counter ( OTC ) medication within 7 day prior Period 1 dosing . Use drug know induce inhibit hepatic drug metabolism within 30 day prior Period 1 dose . On special diet within 4 week prior drug administration ( e.g . liquid , protein , raw food diet ) . Participated another clinical trial receive investigational product within 30 day prior drug administration . Donated 250 mL blood within previous 30 day OR Donated 251 500 mL blood previous 45 day OR Donated 500 mL blood previous 56 day ( base Canadian Blood Services guideline blood donation . Difficulty fast consume standard meal . Do tolerate venipuncture . Unable read sign ICF .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>